Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc. - Common Stock (NQ:MBOT)

2.130 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 403
Open 2.130
Bid (Size) 2.130 (300)
Ask (Size) 2.140 (200)
Prev. Close 2.130
Today's Range 2.130 - 2.130
52wk Range 1.250 - 4.670
Shares Outstanding 67,158,044
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
Adoption of LIBERTY is Consistent with Emory’s Commitment to the Growing and Evolving Field of Interventional Radiology 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
From Microbot Medical Inc.
Via GlobeNewswire

Performance

YTD
+0.9%
+0.9%
1 Month
-9.7%
-9.7%
3 Month
-34.1%
-34.1%
6 Month
-14.1%
-14.1%
1 Year
-25.0%
-25.0%

More News

Read More
News headline image
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Monday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors
From DIH Holding US, Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Added to the Russell Microcap® Index
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
From Microbot Medical Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Microbot Medical Inc. - Common Stock publicly traded?
Yes, Microbot Medical Inc. - Common Stock is publicly traded.
What exchange does Microbot Medical Inc. - Common Stock trade on?
Microbot Medical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Microbot Medical Inc. - Common Stock?
The ticker symbol for Microbot Medical Inc. - Common Stock is MBOT on the Nasdaq Stock Market
What is the current price of Microbot Medical Inc. - Common Stock?
The current price of Microbot Medical Inc. - Common Stock is 2.130
When was Microbot Medical Inc. - Common Stock last traded?
The last trade of Microbot Medical Inc. - Common Stock was at 01/06/26 04:00 PM ET
What is the market capitalization of Microbot Medical Inc. - Common Stock?
The market capitalization of Microbot Medical Inc. - Common Stock is 143.05M
How many shares of Microbot Medical Inc. - Common Stock are outstanding?
Microbot Medical Inc. - Common Stock has 143M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.